Archives for May 29, 2006

← 2006

Solutia sells pharma services biz to Indian firm

By  Kirsty Barnes

India's Dishman Pharmaceuticals & Chemicals has snapped up the Swiss-based pharmaceutical services business, Carbogen and Amcis, of financially-troubled US chemical firm Solutia for the sum of $74.5m (€58m).

HCL stealing business from CROs via India

By  Kirsty Barnes

IT services company HCL Technologies continues to experience rapid growth through its ability to undercut clinical research organisations (CROs) on price for clinical data management (CDM) services through its new operations in India.

Malvern streamlines French contract testing biz

By  Kirsty Barnes

UK-based Malvern Instruments has been busy streamlining its particle characterisation contract testing services at its global locations, with the latest reshuffle taking place in France.

MDS Pharma's formulation branch jumps ship

By  Gregory Roumeliotis

The Tampa-based formulation development laboratory of MDS Pharma Services has split from its parent company and formed a new firm with the technology to get active pharmaceutical ingredients (APIs) directly into capsules.

MFIC's fortunes recover on the back of strong sales

By  Gregory Roumeliotis

MFIC Corporation, whose Microfluidics Division manufactures industrial submicron processing equipment, has returned to profitability in the first quarter of 2006 after big losses in first quarter of last year, buoyed by increased demand from...

Parexel back in hot water over drug trial errors

By  Kirsty Barnes

Although clearing Parexel from contributing to the recent drug trial disaster, a final UK Medicines and Healthcare products Regulatory Agency (MHRA) report slammed the US firm for making a number of basic errors during the trial process.

BASF to showcase new intermediates at ChemSpec

By  Gregory Roumeliotis

BASF is targeting the pharma industry at ChemSpec this June with new intermediates, catalysts and raw materials that promise to make customers' syntheses less complex and time-consuming as well as more cost-effective.